Renub

    United States Anesthesia Drugs Market, Size, Forecast 2024-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis

    Excel: 12 Hours
    PDF: 24 Hours
    Jan 2024
    Pages: 155

    United States Anesthesia Drugs Market Outlook

    United States Anesthesia Drugs Market size is predicted to reach to US$ 3.29 Billion by 2030, as per Renub Research. Anesthesia is the loss of feeling or sensation. It is often administered all through surgical approaches to save pain or soreness. Different medication can be used to set off anesthesia and bring about partial or whole loss of sensation. Anesthetic drugs are not commonly used outside of anesthesia, but many different types are utilized in cutting-edge anesthetic practice. While a few drugs are reserved totally for anesthesia, others are regularly used throughout different scientific disciplines. The anesthesiology industry comprises main factors: anesthesia and anesthesiologists. Many portions of device are specially designed for different surgical techniques. An Anesthetic Vaporizer is used for vaporizing anesthetic, nasal oxygen set for delivering oxygen, and many others.

    Anesthesia is a critical component in almost all surgical processes nowadays, as it helps to numb the ache at during the operation. This type of medical treatment is gaining recognition inside the United States, in particular among those among 50 and 75 years old. The market for anesthesia medicines and devices in the US is experiencing significant increase due to different factors, which include the increasing variety of older adults, the upward push in monitored anesthesia use, the thriving in chronic diseases, and the volume of surgical procedures being accomplished. Over the few decades, the prevalence of cancers has also risen considerably within the US. According to the National Cancer Institute, there are currently round 16.9 million cancer survivors in the USA, a figure that is anticipated to rise to 22.2 million via the year 2030.


    United States Anesthesia Drugs Market is expected to develop at a CAGR of 3.88% all through the 2024-2030

    The demand for anesthesia medicines is rising because of the growing number of surgeries and the approval of recent anesthesia drugs. According to the American Society of Plastic Surgeons, a 3% growth in cosmetic surgical methods, minimally invasive strategies, and reconstructive processes performed in 2020, the United States witnessed an evaluation to the preceding year, with 2.3 Million cosmetic surgical methods, 3.2 million minimally invasive strategies, and 6.8 million reconstructive processes being carried out. As a result, the demand for anesthesia drugs has been growing.

    The anesthesia market is anticipated to develop rapidly due to elevated product launches, strategic acquisitions, and government approvals in the USA. Heron Therapeutics, Inc.'s ZYNRELEF has received approval from Health Canada to provide postoperative pain comfort for surgical techniques including a bunionectomy, open inguinal herniorrhaphy, and total knee arthroplasty. Yet, the market faces particular demanding situations, such as the facet consequences of anesthesia, the high price of anesthesia device. United States Anesthesia Drugs Market turned into valued at US$ 2.52 Billion in 2023.


    Local Anesthesia Drugs Market will have a large proportion in the United States Anesthesia Drugs Market

    The United States Anesthesia Drugs Market is assessed into Inhalation Anesthesia, Intravenous Anesthesia, and Local Anesthesia. Local anesthesia drugs are predicted to enhance USA anesthesia drugs market growth drastically. They provide pain medicine, have moderate and rare aspect results, and are price-effective. Their management reduces the chance of aspiration pneumonia and allows patients to be discharged faster, making them a top-rated choice for medical doctors.


    Sevoflurane is one of the maximums used general anesthetics in surgeries

    The General Anesthesia Drugs Market is hastily advancing, specifically in the use of Sevoflurane, Desflurane, Isoflurane, and other inhalation anesthesia drugs. Sevoflurane, a broadly used drug for inducing and preserving anesthesia in the course of medical procedures, is know for its fast action and quick patient recovery. As the most usually type of anesthesia, sevoflurane, together with desflurane and nitrous oxide, leads the marketplace. Its low pungency, non-worrying smell, and low blood and gas partition coefficient contribute to its popularity. The sevoflurane segment anticipates widespread growth inside the US market, pushed with the aid of improved adoption, rising healthcare expenditure, and ongoing product launches.


    Propofol captured the outmost share inside the General Intravenous Anesthesia Drugs market

    The General Anesthesia Drugs market is classed into Propofol, Etomidate, Ketamine, & Barbiturates. Propofol has emerged as the dominant participant within the General Intravenous Anesthesia Drugs market. Its significant use is attributed to its extensive use onset smooth induction, and quick recovery, making it a favored preference for plenty anesthesia procedures. The drug's protection profile and efficacy have solidified its position, particularly in surgical and diagnostic settings. Propofol's popularity underscores its vital role in ensuring patient comfort and safety during in clinical approaches, establishing it as the frontrunner within the competitive landscape of General Intravenous Anesthesia Drugs.


    Prilocaine Local Anesthesia Drugs market was observing significant growth

    Local Anesthesia Drugs market is split into Bupivacaine, Ropivacaine, Lidocaine, Chloroprocaine, Prilocaine, Benzocaine, and Others. The market for Prilocaine Local Anesthesia Drugs has witnessed massive thriving, pushed through the growing demand for efficient local anesthesia solutions in numerous scientific and dental procedures. Prilocaine, known for its efficacy and safety, has received prominence among healthcare specialists. The Prilocaine Local Anesthesia Drugs market is booming because it keeps to satisfy meet the needs of patients and practitioners alike. This surge underscores the pivotal role of such drugs in improving patient comfort and facilitating scientific interventions, reinforcing Prilocaine's importance in the market.


    Key Players Analysis

    Baxter International Inc, Abbvie, Medtronic Plc, Draegerwerk AG, Koninklijke Philips NV, and Abbott Laboratories are the leading players in the United States Anesthesia Drugs Market.


    Renub Research latest Report “United States Anesthesia Drugs Market by Type (General Inhalation Anesthesia Drugs market, General Intravenous Anesthesia Drugs Market and Local Anesthesia Drugs Market) by General Inhalation Anesthesia Drugs market (Sevoflurane, Desflurane, Isoflurane & Others) by General Intravenous Anesthesia Drugs Market (Propofol, Etomidate, Ketamine & Barbiturates) by Local Anesthesia Drugs Market (Bupivacaine, Ropivacaine, Lidocaine, Chloroprocaine, Prilocaine, Benzocaine & Other local anesthetics) by Company Analysis (Baxter International Inc, Abbvie, Medtronic Plc, Draegerwerk AG, Koninklijke Philips NV and Abbott Laboratories)” provides complete details on United States Anesthesia Drugs Market.


    Type – United States Anesthesia Drugs Market breakup by 3 viewpoints

    1.    General Intravenous Anesthesia Drugs Market
    2.    General Inhalation Anesthesia Drugs Market
    3.    Local Anesthesia Drugs Market


    General Intravenous Anesthesia Drugs Market breakup by 4 viewpoints

    1.    Propofol
    2.    Etomidate
    3.    Ketamine
    4.    Barbiturates


    General Inhalation Anesthesia Drugs Market breakup by 4 viewpoints

    1.    Sevoflurane
    2.    Desflurane
    3.    Isoflurane
    4.    Others


    Local Anesthesia Drugs Market breakup by 7 viewpoints

    1.    Bupivacaine
    2.    Ropivacaine
    3.    Lidocaine
    4.    Chloroprocaine
    5.    Prilocaine
    6.    Benzocaine
    7.    Other local Anesthetics


    Reimbursement Policy – United States Anesthesia Drugs Market 2 viewpoint

    A) Private Health Insurance Providers

    1.    Aetna International
    2.    Coventry Health Care
    3.    Anthem Blue Cross and Blue Shield
    4.    Blue Cross and Blue Shield of Texas
    5.    United Healthcare

    B) Public Health Insurance Providers

    1.    Medicare
    2.    MDWise


    All key players have been covered from 3 viewpoints

    •    Overview
    •    Recent Developments
    •    Revenue


    Company Analysis:

    1.    Baxter International Inc
    2.    Abbvie
    3.    Medtronic Plc
    4.    Draegerwerk AG
    5.    Koninklijke Philips NV
    6.    Abbott Laboratories

     

    Report Details:

    Report Features Details
    Base Year 2023
    Historical Period 2018 - 2023
    Forecast Period 2024 - 2030
    Market US$ Billion
    Segment Covered Type, and Reimbursement Policy
    Companies Covered Baxter International Inc, Abbvie, Medtronic Plc, Draegerwerk AG, Koninklijke Philips NV and Abbott Laboratories
    Customization Scope 20% Free Customization
    Post-Sale Analyst Support 1 Year (52 Weeks)
    Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request)

    1.    Introduction

    2.    Research Methodology

    3.    Executive Summary

    4.    Market Dynamics

    4.1    Growth Drivers
    4.2    Challenges


    5.    United States Anesthesia Drugs Market

    6.    Share Analysis – United States Anesthesia Drugs Market

    6.1    Anesthesia Drugs
    6.2    General Inhalation Anesthesia Drugs Market
    6.3    General Intravenous Anesthesia Drugs
    6.4    Local Anesthesia Drugs


    7.    Types – United States Anesthesia Drugs Market

    7.1    General Inhalation Anesthesia Drugs Market
    7.2    General Intravenous Anesthesia Drugs Market
    7.3    Local Anesthesia Drugs Market


    8.    General Inhalation Anesthesia Drugs Market

    8.1    Sevoflurane
    8.2    Desflurane
    8.3    Isoflurane
    8.4    Others


    9.    General Intravenous Anesthesia Drugs Market

    9.1    Propofol
    9.2    Etomidate
    9.3    Ketamine
    9.4    Barbiturates


    10.    Local Anesthesia Drugs Market

    10.1    Bupivacaine
    10.2    Ropivacaine
    10.3    Lidocaine
    10.4    Chloroprocaine
    10.5    Prilocaine
    10.6    Benzocaine
    10.7    Other local anesthetics


    11.    Merger & Acquisition (M&A) – United States Anesthesia

    12.    Reimbursement Policy – United States Anesthesia Drugs Market 

    12.1    Private Health Insurance Providers

    12.1.1    Aetna International
    12.1.2    Coventry Health Care
    12.1.3    Anthem Blue Cross and Blue Shield
    12.1.4    Blue Cross and Blue Shield of Texas
    12.1.5    United Healthcare

    12.2    Public Health Insurance Providers

    12.2.1    Medicare
    12.2.2    MDWise


    13.    Porter’s Five Forces – United States Anesthesia Drugs Market

    13.1    Bargaining Power of Buyers
    13.2    Bargaining Power of Suppliers
    13.3    Degree of Rivalry
    13.4    Threat of New Entrants
    13.5    Threat of Substitutes


    14.    SWOT Analysis – United States Anesthesia Drugs Market

    14.1    Strength
    14.2    Weakness
    14.3    Opportunity
    14.4    Threat


    15.    Key Players Analysis

    15.1    Baxter International Inc.

    15.1.1    Overview
    15.1.2    Recent Development
    15.1.3    Revenue

    15.2    Abbvie

    15.2.1    Overview
    15.2.2    Recent Development
    15.2.3    Revenue

    15.3    Medtronic Plc

    15.3.1    Overview
    15.3.2    Recent Development
    15.3.3    Revenue

    15.4    Draegerwerk AG

    15.4.1    Overview
    15.4.2    Recent Development
    15.4.3    Revenue

    15.5    Koninklijke Philips NV

    15.5.1    Overview
    15.5.2    Recent Development
    15.5.3    Revenue

    15.6    Abbott Laboratories

    15.6.1    Overview
    15.6.2    Recent Development
    15.6.3    Revenue


    List of Figures:

    Figure-01:    United States – Anesthesia Drugs Market (Billion US$), 2018 – 2023
    Figure-02:    United States – Forecast for Anesthesia Drugs Market (Billion US$), 2024 – 2030
    Figure-03:    Type – General Inhalation Anesthesia Drugs Market Market (Million US$), 2018 – 2023
    Figure-04:    Type – Forecast for General Inhalation Anesthesia Drugs Market Market (Million US$), 2024 – 2030
    Figure-05:    Type – General Intravenous Anesthesia Drugs Market Market (Million US$), 2018 – 2023
    Figure-06:    Type – Forecast for General Intravenous Anesthesia Drugs Market Market (Million US$), 2024 – 2030
    Figure-07:    Type – Local Anesthesia Drugs Market Market (Million US$), 2018 – 2023
    Figure-08:    Type – Forecast for Local Anesthesia Drugs Market Market (Million US$), 2024 – 2030
    Figure-09:    General Inhalation Anesthesia – Sevoflurane Market (Million US$), 2018 – 2023
    Figure-10:    General Inhalation Anesthesia – Forecast for Sevoflurane Market (Million US$), 2024 – 2030
    Figure-11:    General Inhalation Anesthesia – Desflurane Market (Million US$), 2018 – 2023
    Figure-12:    General Inhalation Anesthesia – Forecast for Desflurane Market (Million US$), 2024 – 2030
    Figure-13:    General Inhalation Anesthesia – Isoflurane Market (Million US$), 2018 – 2023
    Figure-14:    General Inhalation Anesthesia – Forecast for Isoflurane Market (Million US$), 2024 – 2030
    Figure-15:    General Inhalation Anesthesia – Others Market (Million US$), 2018 – 2023
    Figure-16:    General Inhalation Anesthesia – Forecast for Others Market (Million US$), 2024 – 2030
    Figure-17:    General Intravenous Anesthesia – Propofol Market (Million US$), 2018 – 2023
    Figure-18:    General Intravenous Anesthesia – Forecast for Propofol Market (Million US$), 2024 – 2030
    Figure-19:    General Intravenous Anesthesia – Etomidate Market (Million US$), 2018 – 2023
    Figure-20:    General Intravenous Anesthesia – Forecast for Etomidate Market (Million US$), 2024 – 2030
    Figure-21:    General Intravenous Anesthesia – Ketamine Market (Million US$), 2018 – 2023
    Figure-22:    General Intravenous Anesthesia – Forecast for Ketamine Market (Million US$), 2024 – 2030
    Figure-23:    General Intravenous Anesthesia – Barbiturates Market (Million US$), 2018 – 2023
    Figure-24:    General Intravenous Anesthesia – Forecast for Barbiturates Market (Million US$), 2024 – 2030
    Figure-25:    Local Anesthesia – Bupivacaine Market (Million US$), 2018 – 2023
    Figure-26:    Local Anesthesia – Forecast for Bupivacaine Market (Million US$), 2024 – 2030
    Figure-27:    Local Anesthesia – Ropivacaine Market (Million US$), 2018 – 2023
    Figure-28:    Local Anesthesia – Forecast for Ropivacaine Market (Million US$), 2024 – 2030
    Figure-29:    Local Anesthesia – Lidocaine Market (Million US$), 2018 – 2023
    Figure-30:    Local Anesthesia – Forecast for Lidocaine Market (Million US$), 2024 – 2030
    Figure-31:    Local Anesthesia – Chloroprocaine Market (Million US$), 2018 – 2023
    Figure-32:    Local Anesthesia – Forecast for Chloroprocaine Market (Million US$), 2024 – 2030
    Figure-33:    Local Anesthesia – Prilocaine Market (Million US$), 2018 – 2023
    Figure-34:    Local Anesthesia – Forecast for Prilocaine Market (Million US$), 2024 – 2030
    Figure-35:    Local Anesthesia – Benzocaine Market (Million US$), 2018 – 2023
    Figure-36:    Local Anesthesia – Forecast for Benzocaine Market (Million US$), 2024 – 2030
    Figure-37:    Local Anesthesia – Other local anesthetics Market (Million US$), 2018 – 2023
    Figure-38:    Local Anesthesia – Forecast for Other local anesthetics Market (Million US$), 2024 – 2030
    Figure-39:    Baxter International Inc. – Market (Million US$), 2018 – 2023
    Figure-40:    Baxter International Inc. – Forecast for Market (Million US$), 2024 – 2030
    Figure-41:    Abbvie – Global Revenue (Billion US$), 2018 – 2023
    Figure-42:    Abbvie – Forecast for Global Revenue (Billion US$), 2024 – 2030
    Figure-43:    Medtronic Plc – Global Revenue (Billion US$), 2018 – 2023
    Figure-44:    Medtronic Plc – Forecast for Global Revenue (Billion US$), 2024 – 2030
    Figure-45:    Draegerwerk AG – Global Revenue (Billion US$), 2018 – 2023
    Figure-46:    Draegerwerk AG – Forecast for Global Revenue (Billion US$), 2024 – 2030
    Figure-47:    Koninklijke Philips NV – Global Revenue (Billion US$), 2018 – 2023
    Figure-48:    Koninklijke Philips NV – Forecast for Global Revenue (Billion US$), 2024 – 2030
    Figure-49:    Abbott Laboratories – Global Revenue (Billion US$), 2018 – 2023
    Figure-50:    Abbott Laboratories – Forecast for Global Revenue (Billion US$), 2024 – 2030


    List of Tables:

    Table-01:    United States – Anesthesia Drugs Market Share (Million US$), 2018 – 2023
    Table-02:    United States – Forecast for Anesthesia Drugs Market Share (Million US$), 2024 – 2030
    Table-03:    United States – General Inhalation Anesthesia Drugs Market Market Share (Million US$), 2018 – 2023
    Table-04:    United States – Forecast for General Inhalation Anesthesia Drugs Market Market Share (Million US$), 2024 – 2030
    Table-05:    United States – General Intravenous Anesthesia Drugs Market Share (Million US$), 2018 – 2023
    Table-06:    United States – Forecast for General Intravenous Anesthesia Drugs Market Share (Million US$), 2024 – 2030
    Table-07:    United States – Local Anesthesia Drugs Market Share (Million US$), 2018 – 2023
    Table-08:    United States – Forecast for Local Anesthesia Drugs Market Share (Million US$), 2024 – 2030

    Related Reports